ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,806Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 2588

$1.86M Total Retail Price of All Prescriptions

Rank: 10 out of 2588

654 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 654 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

14% of this provider’s 654 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 21,668 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

38% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
DIOVAN 850 849 1 29
SIMVASTATIN 767 596 2 1
OMEPRAZOLE 734 622 3 6
AMLODIPINE BESYLATE 730 659 4 4
LEVOTHYROXINE SODIUM 670 584 5 2
METOPROLOL SUCCINATE 619 560 6 12
NEXIUM 572 535 7 41
WARFARIN SODIUM 546 496 8 10
LIDODERM 484 446 9 86
METOPROLOL TARTRATE 471 376 10 9
LISINOPRIL 409 282 11 3
FUROSEMIDE 403 354 12 5
ATORVASTATIN CALCIUM 398 348 13 11
DIOVAN HCT 391 390 14 72
ZOLPIDEM TARTRATE 367 358 15 24
METFORMIN HCL 345 267 16 8
HYDROCODONE-ACETAMINOPHEN 340 175 S3 17 7
POLYETHYLENE GLYCOL 3350 329 317 18 55
CRESTOR 318 276 19 25
TRAMADOL HCL 297 259 20 19
GLIMEPIRIDE 266 238 21 39
HYDROCHLOROTHIAZIDE 259 218 22 13
FAMOTIDINE 258 207 23 36
FLUTICASONE PROPIONATE 256 205 24 40
CARVEDILOL 241 224 25 20
ALENDRONATE SODIUM 234 203 26 21
JANUVIA 231 203 27 60
GABAPENTIN 218 165 28 18
CLOPIDOGREL 198 185 29 30
TAMSULOSIN HCL 197 163 30 23
DONEPEZIL HCL 187 187 31 22
PANTOPRAZOLE SODIUM 183 137 32 28
ISOSORBIDE MONONITRATE ER 160 149 33 49
CITALOPRAM HBR 158 100 34 27
VOLTAREN 153 142 35 161
MIRTAZAPINE 150 139 36 63
LANTUS 149 104 37 47
PLAVIX 139 133 38 43
LIPITOR 138 120 39 114
SYNTHROID 136 131 40 88
RANITIDINE HCL 135 116 41 37
DIVALPROEX SODIUM 135 82 41 89
NIFEDIPINE ER 134 105 43 59
LOSARTAN POTASSIUM 134 109 43 17
MECLIZINE HCL 131 130 45 120
OLANZAPINE 130 78 46 126
ADVAIR DISKUS 128 96 47 48
ATENOLOL 127 114 48 14
NOVOLOG 123 96 49 103
DILTIAZEM 24HR CD 119 113 50 98
ALLOPURINOL 117 92 51 33
LOVAZA 116 91 52 119
QUETIAPINE FUMARATE 112 97 53 74
DIGOXIN 111 111 54 38
SINGULAIR 111 86 54 94
PROCTOZONE-HC 110 101 56 264
ESCITALOPRAM OXALATE 109 109 57 68
RISPERIDONE 108 89 58 57
NAMENDA 107 107 59 32
TRIAMCINOLONE ACETONIDE 106 72 60 106
HEPARIN SODIUM 106 106 60 79
SPIRONOLACTONE 105 65 62 58
POTASSIUM CHLORIDE 104 73 63 15
LOSARTAN-HYDROCHLOROTHIAZIDE 102 92 64 66
IBUPROFEN 101 82 65 62
AZITHROMYCIN 100 82 66 45
BYSTOLIC 100 81 66 110
ENALAPRIL MALEATE 98 95 68 31
HYDRALAZINE HCL 98 87 68 53
SERTRALINE HCL 97 57 70 26
LEVETIRACETAM 94 58 71 90
CALCITONIN-SALMON 93 93 72 203
VERAPAMIL ER 93 78 72 102
CREON 92 89 74 216
BENZTROPINE MESYLATE 90 34 R 75 107
PREDNISONE 89 72 76 42
CIPROFLOXACIN HCL 89 71 76 82
DILTIAZEM ER 86 79 78 150
TRAZODONE HCL 81 51 79 61
ZENPEP 79 72 80 250
PROPRANOLOL HCL 79 78 80 128
ZETIA 76 70 82 69
LEVOFLOXACIN 76 64 82 77
CLONIDINE HCL 75 57 84 54
KLOR-CON M20 74 63 85 52
AMITRIPTYLINE HCL 74 53 R 85 91
FINASTERIDE 74 74 85 97
IPRATROPIUM-ALBUTEROL 74 41 85 104
DICYCLOMINE HCL 73 63 89 215
NIASPAN 73 49 89 115
DIVALPROEX SODIUM ER 73 27 89 121
LIDOCAINE 72 40 92 292
AMLODIPINE BESYLATE-BENAZEPRIL 69 54 93 76
SPIRIVA 69 32 93 56
LOPERAMIDE 67 51 95 238
AMITIZA 67 57 95 302
PRANDIN 66 66 97 355
LISINOPRIL-HYDROCHLOROTHIAZIDE 66 56 97 35
PAROXETINE HCL 65 40 99 71
PROCRIT 65 63 99 316
MONTELUKAST SODIUM 65 36 99 153
CHLORHEXIDINE GLUCONATE 64 61 102 197
NITROSTAT 63 62 103 181
CEPHALEXIN 63 57 103 138
METOCLOPRAMIDE HCL 61 47 105 136
OXYBUTYNIN CHLORIDE ER 60 46 106 85
DILTIAZEM HCL 60 52 106 228
BENICAR 57 49 108 143
ENOXAPARIN SODIUM 55 52 109 176
ENABLEX 55 55 109 304
ABILIFY 55 35 109 134
FORTICAL 54 30 112 293
TOPIRAMATE 54 0 112 167
SODIUM CHLORIDE 53 49 114 168
HUMALOG 53 23 114 141
LANSOPRAZOLE 53 45 114 157
TERAZOSIN HCL 52 52 117 137
SYMBICORT 52 52 117 129
CELEBREX 51 29 119 99
SEROQUEL 51 44 119 186
TRICOR 50 49 121 122
KETOCONAZOLE 50 49 121 195
HALOPERIDOL 50 16 121 154
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 7, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.